top of page

TREATMENT

Leukemia treatment is complex and depends on the type of leukemia, the patient's age and the stage of the disease. It is important to remember that the treatment of the disease may be different in different patients, and one should not be influenced by opinions heard. Each therapeutic decision should be consulted with the attending physician.

 

Here are the main treatment methods used in patients:

 

  • Chemotherapy - used in most cases of leukemia, involves administering cytostatic drugs that destroy cancer cells

  • Immunotherapy - uses drugs that help the immune system fight cancer cells

  • Targeted treatment - involves the use of drugs that target specific molecules involved in the development of leukemia

  • Bone marrow transplantation - used in some cases, especially when other treatments do not bring the expected results

  • Supportive care - includes treatment of infections, blood transfusions, and other methods to improve the patient's overall health. Supportive care aims to relieve symptoms of the disease and the side effects of treatment. It may include the use of painkillers, antibiotics, blood transfusions, and psychological support.

 

Every case of leukemia is different, so treatment is individually tailored to the patient's needs.
The support of a psycho-oncologist or a patient organization specializing in helping patients with hematooncological diseases may prove important in the therapeutic process.

 

Leukemia is a serious disease that requires a complex and multifaceted approach to treatment.
Early diagnosis and appropriate treatment can significantly improve patients' quality of life and increase their chances of recovery.

Prognosis

 

The prognosis for leukemia depends on many factors, such as the type of leukemia, the patient's age, general health, and response to treatment. In recent years, there has been significant progress in the treatment of leukemia. A number of new drugs have been introduced into clinical practice, significantly improving the situation of patients. Bone marrow transplantation has also become a safer and standard procedure. The number of available potential bone marrow donors has also increased significantly, which makes it much easier to find a genetically compatible donor and allows for bone marrow transplantation at the most optimal time for the patient.

Support our
Actions

#becomeourhero

obraz kampanii 1,5%. Osoby w białych koszulach z napisem na zielonym tle "wspieram działania fundacji".

Urszula Jaworska Foundation

Ul. Międzynarodowa 61,
03-922 Warszawa

Email : office@fundacjauj.pl

Phone : 22 870 05 21

KRS: 0000055503
REGON: 012778977
NIP: 113-18-07-560


We would like to inform you that the Foundation's office
works remotely. To arrange a meeting, please contact us in advance.

Write to us

Bank account

Bank Name: ING Bank Śląski
Invoice no.: 03 1050 1025 1000 0022 9627 5312
IBAN: PL03 1050 1025 1000 0022 9627 5312
BIC (SWIFT CODE): INGBPLPW

Quick links

Business card qr code

Qr code directing to all communication channels of the foundation

© 2024 design and implementation: Urszula Jaworska Foundation - All rights reserved

|

|

bottom of page